Table: begin end state 1 19 cytoplasmic 20 38 transmembrane 39 57 non-cytoplasmic 58 77 transmembrane 78 96 cytoplasmic 97 116 transmembrane 117 148 non-cytoplasmic 149 170 transmembrane 171 197 cytoplasmic 198 221 transmembrane 222 236 non-cytoplasmic 237 259 transmembrane 260 270 cytoplasmic 271 299 transmembrane 300 323 non-cytoplasmic 324 346 transmembrane 347 357 cytoplasmic 358 382 transmembrane 383 413 non-cytoplasmic 414 433 transmembrane 434 453 cytoplasmic 454 475 transmembrane 476 482 non-cytoplasmic 483 504 transmembrane 505 514 cytoplasmic
Input: >GFF3740 MSETSMETTPQESRINKPLFLLSGGFIALFCVAALVNLDGLSALVDWGFNIAATYFGLYW QILLLATFLIGLVLCILPGGRAIMGGLATPEFTTFQWGSMIMCTLLAGGGVFWAAGEPIA HFLYSPPLYGAEGGSEAAVTPAIAQSFMHWGFLAWAILGSLSTVMLMHYHYEKGLPLAPR TLLYPVFGDKAINGPIGVIADASSIIAVVAGTVGPIGFLGLQVSYGLSDLFGIPDVFATQ FVVIGALVALYTISAMTGLSRGIQLLSKINVILAAVLLIYVLLAGPTGFIFGSFFSGFAT YLGNFFQMALYRGDAAVFGAPGWLGWWTVFFWGWFMGYGPLMAMFIARVSRGRSIRSIII MLSIIAPIVTNFWFTIIGGTGIAMELAEPGTVSAAFEGFNLPAALLAITNNLPMGFLVSI LFLILTTIFVATTGDSMSYVISATMTKGDTPSTAVRVFWGIAMGVMAVILISVGSGGVSK LQSFIVVTAVPVSLILLPSLWDALRITLAKGKES
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server